Nexavar
Nexavar Official FDA information, side effects and uses.
Posted by Nexavar (Nexavar) on Sun, 26 Aug 2007 00:17:07 +0000
Bayer AG and Onyx Pharmaceuticals Inc. said Monday the Food and Drug Administration gave priority review for the application of its drug Nexavar as a liver cancer treatment.
Bayer erhält von FDA "Priority Review"-Status für Nexavar (OnVista)
Wie bewerten Sie diese Seite? sehr gut 1 2 3 4 5 6 schlecht © 1998-2007 OnVista Group - Die OnVista Media GmbH übernimmt keine Haftung für die Richtigkeit der Angaben!
Staff Writer (BioWorld)
On the heels of a $15 million Series C financing, Adnexus Therapeutics Inc. filed for an initial public offering, hoping to raise as much as $86 million to fund ongoing work with its anti-angiogenic drug, Angiocept, and other early stage Adnectin-based products.
Nexawar from Bayer, ONYX gets priority status from US FDA (New Ratings)
NEW YORK, August 20 (newratings.com) – Bayer AG and ONYX Pharmaceuticals, Inc ( ONXX.NAS ) Monday announced that the new drug application for their jointly developed Nexavar drug was granted priority review status by the Food and Drug Administration (FDA).
German shares flat afternoon as Bayer, VW help offset weak financials, ZEW index (FinanzNachrichten)
FRANKFURT (Thomson Financial) - German shares were largely flat in afternoon trade as German indices took a momentary break from today's roller-coaster ride.
